Alp Regenerative Medicine Technology

Alp Regenerative Medicine Technology is a biotechnology company specializing in the development of next-generation regenerative therapies using induced pluripotent stem cell (iPSC) technology. The company focuses on creating standardized, high-purity cell products to treat degenerative diseases that currently lack effective cures, such as Parkinson disease and spinal cord injuries. By leveraging its proprietary differentiation and purification platforms, Alp aims to provide scalable and off-the-shelf cell therapy solutions. Their research encompasses a broad range of therapeutic areas, including neurology, ophthalmology, and cardiology. The company is positioned as a leader in the Chinese regenerative medicine sector, emphasizing clinical translation and industrial-scale manufacturing of iPSC-derived products.